Since the recommendations for treatment of hypertension differ according to ethnic groups and age, we considered the possibility that these factors might contribute to the observed association between ACE inhibitor or ARB use and COVID-19 disease or severity. The gene discussed is ACE; the disease is hypertensive disorder.